Xujie Zhao

6PUBLICATIONS
24CO-AUTHORS
Discourse and pragmaticsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion.

|Jan 23, 2025
Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells.

Yibi Zhang, Xiaodong Wang, Yinmin Gu

|Nov 28, 2023
Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens.

Shaela Wright, Xujie Zhao, Wojciech Rosikiewicz

|Sep 14, 2022
Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.

Xujie Zhao, Ping Wang, Jonathan D Diedrich

|Jul 08, 2021
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir.

Rina Nishii, Takanori Mizuno, Daniel Rehling

|Feb 16, 2016
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Takaya Moriyama, Rina Nishii, Virginia Perez-Andreu

Pageof 1

Frequent Collaborators

3 joint publications

Jun J Yang

2 joint publications

Beisi Xu

2 joint publications

Shan Gao

1 joint publications

Tatsuo Ichinohe